The Swiss Institute for Sound Medicine
We welcome you to contact us - and look forward to connecting

Content from Calendly can't be displayed due to your current cookie settings. To show this content, please click "Consent & Show" to confirm that necessary data will be transferred to Calendly to enable this service. Further information can be found in our Privacy Policy. Changed your mind? You can revoke your consent at any time via your cookie settings.
About the Founder & CEO
Dr. Miriam Lee Burger, MD, MSc, is a physician-scientist, former concert violinist, and founder of Somnea GmbH — The Swiss Institute for Sound Medicine & Neuroacoustics, based in Zürich. Her work sits at the intersection of clinical medicine, psychoacoustics, and the healing arts, with a focus on sound-based interventions for brain health, burnout prevention, and longevity.
A graduate of the Medical University of Vienna (Medical Doctorate) and the University of Geneva (Global Health, MSc), Dr. Lee Burger holds advanced training from Harvard Medical School (Mind Body Medicine) and Harvard School of Public Health (Global Health Delivery), and is a Swiss FMH candidate in Psychiatry-Psychotherapy. She brings over three decades of professional musicianship — rooted in Russian-Georgian classical training — and a decade of field work in sound therapy and traditions — to her clinical and research practice.
Her institutional roles span global health policy and frontier science: she serves as a contractor to the UN Taskforce on Space Technologies for Global Health, holds an ESA fellowship following her 2024 Space & Global Health Hackathon win, and was preselected by the Swiss Space Office for an ISS mission (2027–2029). In 2025, she joined the 260-physician cohort co-developing HealthBench AI, the inaugural joint AI initiative by OpenAI and Harvard University.
Dr. Lee Burger has contributed to mandates for the WHO, UN-Habitat, and the Vatican, and has advised European venture capital on music medtech innovation. Her sound-based approaches to clinical care have been recognized as healthcare novelties in Austria and the United Kingdom.